Crizotinib in anaplastic large-cell lymphoma

N Engl J Med. 2011 Feb 24;364(8):775-6. doi: 10.1056/NEJMc1013224.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anaplastic Lymphoma Kinase
  • Crizotinib
  • Female
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / drug therapy*
  • Male
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Pyridines / adverse effects
  • Pyridines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases
  • Recurrence
  • Salvage Therapy
  • Young Adult

Substances

  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Crizotinib
  • Anaplastic Lymphoma Kinase
  • Protein-Tyrosine Kinases
  • Receptor Protein-Tyrosine Kinases